Session Details
[FP7]Free Paper 7
Thu. Jun 18, 2026 2:15 PM - 3:15 PM JST
Thu. Jun 18, 2026 5:15 AM - 6:15 AM UTC
Thu. Jun 18, 2026 5:15 AM - 6:15 AM UTC
ポスター会場（パシフィコ横浜ノース 1F G1～G4）FP1,FP4,FP7,FP10,FP13,FP16
Chairperson：Yasuhiro Miyano（Kunpuukai Yamada Hospital）
[1-FP7-1]演題取り下げ
Rina Taniguchi1, Yuichi Esaki1,2, Kenji Obayashi3, Keigo Saeki3, Soji Tsuboi1, Kiyoshi Fujita1, Nakao Iwata2, Tsuyoshi Kitajima2 (1.Department of Psychiatry, Okehazama Hospital, 2.Department of Psychiatry, Fujita Health University School of Medicine, 3.Department of Epidemiology, Nara Medical University School of Medicine)
[1-FP7-2]アリピプラゾールLAI無効例の病態と背景因子の分析
Yasuhiro Miyano (Kunpuukai Yamada Hospital)
[1-FP7-3]統合失調症に関するガイドライン教育が精神科医の治療行動に及ぼす波及効果：多施設共同研究
Toru Horinouchi1, Yusuke Arai2, Hiroyuki Muraoka4, Kazuhiko Yamamuro5, Naoki Hashimoto1, Kazutaka Ohi6, Hikaru Hori7, Yasui-norio Furukori8, Junya Matsumoto3, Ken Inada4, Koichiro Watanabe9, Shinichiro Ochi10, Takashi Tsuboi9, Yasushi Kawamata8, Ryota Hashimoto3 (1.Department of Psychiatry, Hokkaido University Graduate School of Medicine, 2.Department of Psychiatry, Shinshu University School of Medicine, 3.Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4.Department of Psychiatry, Kitasato University, School of Medicine, 5.Center for Health Control, Nara Medical University, 6.Department of Psychiatry, Gifu University Graduate School of Medicine, 7.Department of Psychiatry, Faculty of Medicine, Fukuoka University, 8.Department of Psychiatry, Dokkyo Medical University School of Medicine, 9.Department of Neuropsychiatry, Kyorin University School of Medicine, 10.Department of Neuropsychiatry, Ehime University Graduate School of Medicine)
[1-FP7-4]クロザピンを新規導入した18例における著効例、脱落例の経過について
Masashi Matsumoto (Midorinokaze Minamichitabyouin Ikyoku)
[1-FP7-5]日本のEGUIDE参加施設における治療抵抗性統合失調症の有病率とクロザピン治療率：全国多施設共同研究
Yusuke Arai1, Hiroyuki Muraoka2, Kazuhiko Yamamuro4, Yuka Yasuda3,5, Toshinori Nakamura1, Shinichiro Ochi6, Hirotaka Yamagata3, Toru Horinouchi7, Yasushi Kawamata8, Keisuke Mori3, Kazutaka Ohi9, Hashimoto Naoki7, Junichi Iga6, Matsumoto Junya3, Ken Inada2, Hikaru Hori10, Norio Furukori8, Ryota Hashimoto3 (1.Department of Psychiatry, Shinshu University School of Medicine, 2.Department of Psychiatry, Kitasato University, School of Medicine, 3.Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4.Center for Health Control, Nara Medical University, 5.Life Grow Brilliant Mental Clinic, Medical Corporation Foster, 6.Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, 7.Department of Psychiatry, Hokkaido University Graduate School of Medicine, 8.Department of Psychiatry, Dokkyo Medical University School of Medicine, 9.Department of Psychiatry, Gifu University Graduate School of Medicine, 10.Department of Psychiatry, Faculty of Medicine, Fukuoka University)
[1-FP7-6]統合失調症患者において興奮・躁症状と陰性症状がHbA1cと関連する
Genki Koyama1,2, Riku Yonezawa1, Haruki Makino1, Ryu Nakarai1, Masaki Nakano1, Riko Wakisaka1,3, Taketo Takata2, Hiroyuki Uchida1, Michitaka Funayama1,2 (1.Department of Neuropsychiatry, Keio University School of Medicine, 2.Department of Neuropsychiatry, Ashikaga Red Cross Hospital, 3.Department of Emergency and Critical Care Medicine, Nippon Medical School)